| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2005-11-16 15:48:42 UTC |
|---|
| Updated at | 2025-02-11 15:41:00 UTC |
|---|
| NP-MRD ID | NP0000742 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 1-Methylnicotinamide |
|---|
| Description | 1-Methylnicotinamide is a metabolite of nicotinamide and is produced primarily in the liver. It has anti-inflammatory properties (PMID 16197374 ). It is a product of nicotinamide N-methyltransferase [EC 2.1.1.1] In the pathway of nicotinate and nicotinamide metabolism (KEGG). 1-Methylnicotinamide may be an endogenous activator of prostacyclin production and thus may regulate thrombotic as well as inflammatory processes in the cardiovascular system (PMID: 17641676 ). |
|---|
| Structure | InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Methyl nicotinamide | ChEBI | | 1-Methylnicotinamide cation | ChEBI | | 3-(Aminocarbonyl)-1-methylpyridinium | ChEBI | | 3-Carbamoyl-1-methylpyridin-1-ium | ChEBI | | N(1)-Methylnicotinamide | ChEBI | | N-1-Methylnicotinamide | ChEBI | | Trigonellinamide | ChEBI | | 1-Methyl-3-carbamoylpyridinium | HMDB | | 1-Methyl-3-carbamoylpyridinium cation | HMDB | | 3-Amido-N-methylpyridinium: 1-methyl-3-pyridinecarboxamide | HMDB | | 3-Carbamoyl-1-methyl-pyridinium | HMDB | | I-methyl nicotinamide | HMDB | | N'-methylnicotinamide | HMDB | | N'Methylnicotinamide | HMDB | | N-Methyl-3-carbamidopyridinium | HMDB | | N-Methyl-3-carbamoylpyridinium ion | HMDB | | N1-Methylnicotinamide | HMDB | | N(1)-Methylnicotinamide chloride | HMDB | | N(1)-Methylnicotinamide cyanide | HMDB | | N(1)-Methylnicotinamide fluoride | HMDB | | N(1)-Methylnicotinamide iodide, 3-(aminocarbonyl-13C)-labeled | HMDB | | N(1)-Methylnicotinamide methylsulfate | HMDB | | N(1)-Methylnicotinamide perchlorate | HMDB | | N(1)-Methylnicotinamide bromide | HMDB | | N(1)-Methylnicotinamide iodide | HMDB | | N(1)-Methylnicotinamide tetrafluoroborate (1-) | HMDB | | Trigonellamide chloride | HMDB |
|
|---|
| Chemical Formula | C7H9N2O |
|---|
| Average Mass | 137.1592 Da |
|---|
| Monoisotopic Mass | 137.07149 Da |
|---|
| IUPAC Name | 3-carbamoyl-1-methylpyridin-1-ium |
|---|
| Traditional Name | 1-methylnicotinamide |
|---|
| CAS Registry Number | 3106-60-3 |
|---|
| SMILES | C[N+]1=CC=CC(=C1)C(N)=O |
|---|
| InChI Identifier | InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1 |
|---|
| InChI Key | LDHMAVIPBRSVRG-UHFFFAOYSA-O |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, simulated) | v.dorna83@yahoo.com | Not Available | Not Available | 2021-08-02 | View Spectrum |
| | Species |
|---|
| Species of Origin | |
|---|
| Species Where Detected | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyridines and derivatives |
|---|
| Sub Class | Pyridinecarboxylic acids and derivatives |
|---|
| Direct Parent | Nicotinamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Nicotinamide
- N-methylpyridinium
- Pyridinium
- Heteroaromatic compound
- Vinylogous amide
- Carboxamide group
- Primary carboxylic acid amide
- Carboxylic acid derivative
- Azacycle
- Organic nitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic cation
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 855 mg/mL | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Pelletier O, Brassard R: Automated and manual determination of N1-methylnicotinamide in urine. Am J Clin Nutr. 1977 Dec;30(12):2108-16. [PubMed:145178 ]
- Carter EG: Quantitation of urinary niacin metabolites by reversed-phase liquid chromatography. Am J Clin Nutr. 1982 Nov;36(5):926-30. [PubMed:6215856 ]
- Patterson JI, Brown RR, Linkswiler H, Harper AE: Excretion of tryptophan-niacin metabolites by young men: effects of tryptophan, leucine, and vitamin B6 intakes. Am J Clin Nutr. 1980 Oct;33(10):2157-67. [PubMed:6448542 ]
- Musfeld C, Biollaz J, Belaz N, Kesselring UW, Decosterd LA: Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow. J Pharm Biomed Anal. 2001 Jan;24(3):391-404. [PubMed:11199218 ]
- Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A: Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol. 2005 Nov;30(6):632-5. [PubMed:16197374 ]
- Chlopicki S, Swies J, Mogielnicki A, Buczko W, Bartus M, Lomnicka M, Adamus J, Gebicki J: 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br J Pharmacol. 2007 Sep;152(2):230-9. Epub 2007 Jul 16. [PubMed:17641676 ]
|
|---|